A hospital-based transitional care program for patients with heart failure or pulmonary disease failed to reduce 30- or 90-day readmissions or emergency department visits.
Economic evaluations of adjuvant trastuzumab were reviewed. Three primary shortcomings were identified including incorporation of local data and estimation and representation (visual) of decision uncertainty.
This study shows that telephonic disease management was not cost-effective in a broadly representative sample of community-dwelling patients.
New value frameworks should incorporate real-world evidence that reflects patient treatment behavior, adherence to medication, and equity concerns arising from disparities in care.
Team-based performance incentives may improve healthcare team performance, but provider organizations face a number of structural, technical, and cultural barriers to adopting them.
This systematic review examines the impact of bipolar disorder on employee attendance and functioning at work, along with the associated economic burden to US employers.
Patient characteristics such as psychiatric diagnosis were associated with variations in adherence, although physician characteristics were not.
Patient-reported outcomes, through the use of new technological advances, can be successfully integrated into routine orthopedic practice and shared across distinct institutions.
This report shows that a successful, cost-effective statin switch program can be implemented by a large physician group via a centralized, collaborative process.
Typical health plan data provide limited information for benchmarking physician performance using even a less stringent rule for attributing patient measures to physicians.
The pioglitazone safety warning issued in South Korea, which recommended prescribing with careful attention among those with high risk of bladder cancer, led to a moderate decrease in pioglitazone users.
This study examined the association between health insurance design features and choice of physical therapy or chiropractic care by patients with new-onset low back pain.
In this database analysis, greater adherence was observed for once-daily dosing compared with twice-daily dosing with chronic-use prescription medications used by patients with cardiovascular disease.